Irshaid Y, al-Hadidi H, Abuirjeie M, Latif A, Sartawi O, Rawashdeh N
Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid.
Eur J Clin Pharmacol. 1992;43(6):621-3. doi: 10.1007/BF02284960.
The acetylator phenotype was determined in 31 insulin-dependent (IDDM) and 110 noninsulin-dependent (NIDDM) Jordanian diabetics, and was compared to that of 160 healthy volunteers of the same ethnic group. Dapsone was used as the test drug. The rapid acetylator phenotype was slightly less frequent in IDDM and slightly more frequent in NIDDM. Neither of the differences was significant. When acetylator status in the two types of diabetes mellitus was compared, there was a significant difference among the two groups. Patients with IDDM had a higher percentage of the slow acetylator phenotype when compared to NIDDM patients. The association between acetylator status and IDDM in Jordanians, which agrees with that reported for the Saudi Arabian population, is the reverse of what is found in European populations. The results demonstrate ethnic differences in acetylator status among IDDM patients.
在31名约旦胰岛素依赖型糖尿病(IDDM)患者和110名非胰岛素依赖型糖尿病(NIDDM)患者中测定了乙酰化表型,并与160名同种族健康志愿者的乙酰化表型进行了比较。使用氨苯砜作为测试药物。快速乙酰化表型在IDDM患者中略少,在NIDDM患者中略多。但这两种差异均无统计学意义。当比较两种糖尿病类型的乙酰化状态时,两组之间存在显著差异。与NIDDM患者相比,IDDM患者中慢乙酰化表型的比例更高。约旦人中乙酰化状态与IDDM之间的关联与沙特阿拉伯人群的报道一致,与欧洲人群的情况相反。结果表明IDDM患者的乙酰化状态存在种族差异。